Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 27;73(3):596–606. doi: 10.1093/jac/dkx430

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

PMC Copyright notice

Figure 3. — Joint assessment of drug efficacy and side effects (drug in the row compared with drug in the column). Symbols: >, higher drug efficacy, or more side effects than comparator drug; <, lower drug efficacy, or fewer side effects than comparator drug; =, no evidence of higher or lower drug efficacy, or of more or fewer side effects than comparator drug; o, side effects were not assessed for this comparison. ABZ, albendazole; AGA, Anethum graveolens; CQ, chloroquine; FZD, furazolidone; MBZ, mebendazole; MEN, Mentha crispa; MTZ, metronidazole; NTZ, nitazoxanide; OLZ, oleozon; OZN, ornidazole; PLA, placebo; PPS, propolis; PRM, paromomycin; PZQ, praziquantel; QC, quinacrine; SAU, sausalin; SCZ, secnidazole; TNZ, tinidazole. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.